Taro9-医薬品索引集２０１２－１.
|
|
|
- ちかこ えいさか
- 7 years ago
- Views:
Transcription
1 250mgCCL % CCL gABPC gPIPC mg CFDN g PIPC % CFDN AMPC mg CPDX-PR 82.9 = 5% CPDX-PR AMPC mg CFPN-PI % CFPN-PI CDTR-PI mg 38.8 AMPC/CVA 1.5gAMPC/SBT PIPC/TAZ g IPM/CS gPAPM/BP g MEPM g CEZ mgKM g CTM g KM mgAMK g CMZ mg AMK mgGM %10gGM Na 1gCTRX g gCAZ cm FRM gFMOX gFMOX mgABK = 200mg 1gCZOP gCFPM g CPZ/SBT mgAZM mgCAM mgCAM % CAM mgRXM mgAZM mg % AZM
2 150mgFRPM mg LVFX mgCPFX mgGRNX mgPZFX mgMINO mg/250ml CPFX 2% MINO 21.4 = mgMINO = MEEKVCM MEEKVCM 50 PL-B mgCLDM mgCLDM mgCLDM g Ara-A mgAra-A mg VACV % ACV mgACV mgFOM 68.3= 400FOM %5g ACV gFOM mg 12705* BC mg Cap75mg % mgINH mgEB mgRFP 28.8 = Cap100mg mg
3 100mg/mlAMPH-B mgFLCZ F-FLCZ %5g MCZ mgITCZ mg %10g %10ml %10g %10ml %10g %10ml mg mg PPD -3-
4 10mg NK mg NK 16670* = 2mg mg mg 11915* = 100mg 34996* 20mg 19660* 80mg 67304* 10mg mg mg = 156.7mg = LA10.8mg 76883* * 1mg mg20ml = 50mg 38142* 100mg 70284* 40mg mg 15600* 100mg mg mg/4ml 49959* Cap T T T mg g 16770* 25mg NK mg NK = 25mg
5 0.5mg mg % mg mg mg mg mg mg mg mg % 9.1 5mg mg mg mg mg mg5ml mg = 100mg mg = 100mg mg mg %1ml mg mg 0.4% mg 0.4% % mg mg mg mg %10ml mg %5g mg %5g %5g g %5g %50ml %5g g ml % %5g %40g ug/cm 5cm 10cm mg %5g mg %5g mg %5g ug mg ml mg mg
6 10mg % mg mg mg mg mg mg mg % mg % mg 8.8 2mg % mg mg 0.5ml 15309* 20mg % mg mg mg mg mg mg mg % mg mg mg mg g mg % % mg % mg mg % %
7 HMG-CoA 10mg mg mg /ml mg mg mg mg mg g mg mg mg mg mg mg mg mg mg mg mg mg mg mg mg mg/1g/ mg mg 0.625mg mg mg
8 25mg mg mg % mg mg g g 21.1 B % mg g mg mg g g g mg mg mg mg mg %10ml mg mg
9 20ml ml ml mEq ml mg 8mEq ml mg 1.8mEq ml mEq/g ml0kcal ml 100kcal %20ml ml50kcal %250ml ml100kcal %20ml ml 20kcal mEq ml 52kcal %20ml ml 150kcal %100ml ml 200kcal %250ml ml54kcal %500ml ml 21kcal %20ml %20ml %200ml ml 47kcal ml 400kcal g ml/ 200kcal ml 160kcal ml/ 400kcal g ml210kcal ml %100ml200kcal ml RF 500ml 1000kcal ml660kcal ml820kcal ml 560kcal ml 840kcal ml 1160kcal ml840kcal ml1230kcal
10 5% 12.5g/250ml mg10ml % 12.5g/50ml mg 10.8 = 2.5g 18328* 250mg mg10ml 64.0 = H ml37831* ml 44709* * 1g 20475* 1% 20413* /10ml %25g %50g g mg mg mg mg % * 50mg mg2ml * mg * 100mg * 20 g mg 5.8 1% mg mg2ml
11 ACE 5mg mg 69.2 A 8mg mg mg mg mg mg mg2ml mg 23.4 = 8mg 6.25mg 50mg = 20mg 16mg mg = 8mg 5mg 10mg mg mg mgNTG mg/10ml NTG mg mg/100ml NTG mg mg NTG mg mgISMN mgISDN mg mg mg 7.1 5mg2ml mg mg mg mg mg mg mg mg mg2ml mg10ml mg mg mg = 50mg 20mg
12 200mg2ml 95.0 KY 0.125mg mg mg1ml mg mg mg mg b 2% mg200ml = 2%5ml 100mg5ml mg mg1ml mg mg1ml % mg 85.8 = 50mg mg 50mg5ml mg mg1ml mg mg TE mg = Cap 1000 g mg g g g1ml g2ml g mg IU
13 2mg mg mg mg % mg2ml 61.0 LA 200mg mg mg10ml mg mg mg % mg1ml mg mg1ml mg % g ml mg %300ml mg %200ml mg % g g g/ml g g g g g
14 0.5mg5ml mg20ml mg mg % mg mg2ml mg mg mg mg mg mg % % % mg mg % g 330mg % % % mg mg2ml mg mg1ml mg % mg % mg mg mg mg mg % mg mg
15 30mg mg mg mg mg mg g % % mg mg % % mg mg % % mg mg % % mg mg % 30.3 = % g 330mg mg 5.0 = mg %10ml % ml ml ml
16 100mg mg mg 7.8 5mg1ml mg mg mg mg ml = C 3mg mg mg mg ml mg mg ml SSRI 4.74g mg % mg g mg SNRI 25mg mg mg mg mg mg = 10mg mg ml mg10ml 90.0 = -16-
17 10% % mg1ml mg5ml mg 0.5mg mg mg % mg mg % mg % mg mg % 200mg 6.8 2mg 32.8 = 1mg mg mg mg mg1ml mg mg mg mg mg mg mg mg 6.7 2mg mg mg mg %20ml %250ml mg mg = mg mg mg
18 2mg g % 15.6 L mg1ml mg mg mg mg mg mg % 61.9 Cap100mg 79.2 MAO-B 2.5mg mg 10.1 = 1mg AS 93.0 = 4mg mg 15.4 Cap25mg mg 37.3 Cap10mg %10ml 90.0 = 10% mg mg200ml = 30mg mg mg mg mg mg mg mg mg mg mg
19 0.4%20ml mg1ml mg5ml %5ml mg %10ml mg %5ml mg %20ml %20ml mg %20ml mg %30ml mg %80g %100ml mg2ml mg3ml mg %5ml mg %10ml mg % %100ml mg1ml g mg mg2ml mg mg ml 17225* 0.4mg mg1ml mg 250mg10ml %20ml
20 0.1%5ml %5g mg %5ml % g %5ml %5ml %5ml %5ml %5ml %10ml %5ml %5ml %5ml %10ml %5ml mg5ml mg %5ml %5ml %5ml %5ml %5g %5ml %5ml %5ml %5ml %5ml %3g %5ml %5ml %5ml %5ml % %2.5ml %2.5ml %5ml g %5ml %5ml mg5ml %5ml %5ml %2.5ml %3g %2.5ml %5ml ml %5ml %5ml %5ml %5ml g %3.5g
21 0.5% mg %20g g M mg mg % mg mg %5g %5g mg * 0.2mg %50g mg %30g mg %30g mg g Cap15mg %50g g mg g mg 10mg 5%30ml mg 1mg g ml * IU 26260* 2g/ g/ g %25g mg5ml mg g
22 5ml ml mg mg %5g g g g20ml mg20ml mg1ml /220ml 11031* 300/ * * 300/ * 8.4%20ml / %250ml / / * 370/ %20ml 100ml ml 1% %2ml /10ml ml ml 0.5mg ml mg ml 10130* 12788* * 10 5ml ml
Taro9-医薬品目次２０１２－１.PDF
5 0.1% 11 250mg 10 20mg 10 5ml 19 0.05% 13 1.25mg 10 1%5ml 19 10mg 10 0.2%100ml 18 25%50ml 9 2mg 17 5%250ml 9 20%25g 20 500 g 11 4 10g 20 Cap150mg 1 200mg 0 Cap90mg 5 20mg 10 10% 5 18 10mg 10 3%30g 20
A5_Catalog-US-JN_ indd
66 22 g 13 g 8 g 5 g 7500 IU 150% 300 mg 600 IU 100 IU 80 mcg 3 mg 3.5 mg 40 mg 4 mg 500 mcg 12 mcg 300 mcg 20 mg 1000 mg 150 mcg 400 mg 15 mg 105 mcg 2 mg 2 mg 180 mcg 125 mcg 15 mg 3.6 g ** 3.8 g **
薬局におけるインシデント事例の集計･分析結果
13 11 14 31 13 11 14 31 13 11 14 31 10 13 13 e-mail 18 4,000 13 14 H13.4.1 11.17 11.18 H14.3.31 13 14 31-1- 600 400 (18.4 17.7 17.0 16.0 15.2 8.2 1.0 2 11 10 12 15 3 1015203040 69.5 7.8 22.7 4 (42.5) 34.3
レイアウト 1
1 3 6 7 8 3 6 7 8 g mg 6 1 16 16 18 16 13 138 13 16 1 11 8 78 8 17 9 9 g mg 18 13 1 1 1 99 6 3 36 3 3 8 1 18 18 18 16 16 1 1 g mg 1 1 13 13 1 11 11 g mg 8 6 g 1 g mg 93 38 9 93 8 8 176 1 1 1 1 11 18
I
I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4
g 51 52
10 12 A 12 C 12 13 13 13 13 16 16 18 18 18 23 23 23 23 23 A 24 25 25 26 28 28 30 32 38 38 41 42 43 10 43 11 45 48 48 120g 51 52 12 3 12 3 350g 120g 1 7 10 260g 90g 90g 30g 9 11 2 gg1 g 1 120g 10 1 12 6
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
8 8 0
,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7
レジャー産業と顧客満足の課題
1 1983 1983 2 3700 4800 5500 3300 15 3 100 1000 JR 4 14 2000 55% 72% 1878 2000 5 ( ) 22 1,040 5 946 42 15 25 30 30 4 14 39 1 24 8 6 390 33 800 34 34 3 35 () 37 40 1 50 40 46 47 2 55 4.43 4 16.98 40 55
Staphylococcus epidermidis Streptococcus pneumoniae Staphylococcus epidermidis Streptococcus pneumontae S. epidermidis Table 1. Summary of the organis
Staphylococcus aureus S. aureus (MRSA) vancomycin (VCM), arbekacin (ABK) Streptococcus pneumoniae cefuzonam (CZON), cefpirome (CPR) S. pneumoniae Enterococcus faecalis ampicillin (ABPC), imipenem (IPM)
「薬剤耐性菌判定基準」 改定内容
Ver.3.1 Ver.3.2 改訂内容 (2019 年 1 月 ) 改訂対象改訂前改訂後 メチシリン耐性黄色ブドウ球菌 (MRSA) ペニシリン耐性肺炎球菌 (PRSP) 多剤耐性緑膿菌 (MDRP) 多剤耐性アシネトバクター属 (MDRA) 概要 MPIPC が R の Staphylococcus aureus ( または CFX がディスク拡散法で R ) または選択培地で MRSA と確認された菌微量液体希釈法の基準
1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14
3 9 11 25 1 2 2 3 3 6 7 1 2 4 2 1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14 60 m3 60 m3 4 1 11 26 30 2 3 15 50 2 1 4 7 110 2 4 21 180 1 38
, 360ml P , 360ml P , 360ml P , 40, 720ml P , 14, 2
3-1 3-1 20 2600, 20, 360ml P.35 3-2 3-2 16 2700, 16, 280ml P.35 3-3 3-3 20 2600, 20, 360ml P.35 3-4 3-4 19 2600, 19, 340ml P.35 3-5 3-5 20 2900, 20, 360ml P.35 3-6 3-6 18 3000, 18, 320ml P.35 3-7 3-7 18
km2 km2 km2 km2 km2 22 4 H20 H20 H21 H20 (H22) (H22) (H22) L=600m L=430m 1 H14.04.12 () 1.6km 2 H.14.05.31 () 3km 3 4 5 H.15.03.18 () 3km H.15.06.20 () 1.1km H.15.06.30 () 800m 6 H.15.07.18
RF_1
RF_1 10/04/16 10:32 http://rftechno.web.infoseek.co.jp/rf_1.html 1/12 RF_1 10/04/16 10:32 http://rftechno.web.infoseek.co.jp/rf_1.html 2/12 RF_1 10/04/16 10:32 http://rftechno.web.infoseek.co.jp/rf_1.html
Microsoft PowerPoint ．片山（HP用修正）.pptx
平成 29 年度 第 1 回三重県感染対策 援ネットワーク研修会 2017/07/09 ( 臨床第 2 講義室 ) 講演 2 アンチバイオグラムの活 アンチバイオグラム作り 使い 独 政法 地域医療機能推進機構 四 市 津医療センター 薬剤科 副薬剤科 歳也 Japan Community Health care Organization (JCHO) Yokkaichi Hazu Medical
1 1 2 2 3 3 4 5 5 6 6 7 7 8 8 9 9 10 10. 11 1 12 1 13 2 13 3 8 13 4 14 5 14 6 14 7 15 8 15 1 17 2 22 3 24 4 24 1 33 2 42 1 49 2 50 3 50 4 56 1 60 2 88 3 93 1 95 2 96 1 98 2 100 1 100 2 104 3 105 4 105
p.01....
40 2 Vol. 22 No. 82000 10 10 12 21 Vol. 22 No. 82000 3 1858 13 1842 1862 1868 1871 1872 1836 4 Vol. 22 No. 82000 5 Vol. 22 No. 82000 1871 1869 10 12 187514 ü 6 Vol. 22 No. 82000 600 1,200 1020 100 18431883
Microsoft Word - 観光と食 2・3 食品添加物 vs. 質の事業.doc
2 1. Ø 90 15 100 130 3 Ø Ø Ø Ø Ø ph Ø Ø ph Ø Na Na CMC OKINAWA UNIVERSITY 1/13 Na Na V.C ph ph Ø C g mg Ø ml g Ø Ø V.C g C mg 50kcal g Ø OKINAWA UNIVERSITY 2/13 Ø Ø Na Ø Ø Ø Ø Ø Ø Ø 1. 2. 3. 4. Ø OKINAWA
R06_01
Staphylococcus aureus (MSSA) PCG (N=118,334) 57,369 (48.5%) 判定不能 :3 (0.0%) 60,962 (51.5%) CEZ (N=143,723) I:42 (0.0%) 143,635 (99.9%) R:46 (0.0%) CVA/AMPC (N=19,281) R:14 (0.1%) 19,265 (99.9%) 判定不能 :2
H27 28 4 1 11,353 45 14 10 120 27 90 26 78 323 401 27 11,120 D A BC 11,120 H27 33 H26 38 H27 35 40 126,154 129,125 130,000 150,000 5,961 11,996 6,000 15,000 688,684 708,924 700,000 750,000 1300 H28
1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%
無印良品のスキンケア
2 3 4 5 P.22 P.10 P.18 P.14 P.24 Na 6 7 P.10 P.22 P.14 P.18 P.24 8 9 1701172 1,400 1701189 1,000 1081267 1,600 1701257 2,600 1125923 450 1081250 1,800 1125916 650 1081144 1,800 1081229 1,500 Na 1701240
裁定審議会における裁定の概要 (平成23年度)
23 23 23 4 24 3 10 11 12 13 14 () 1 23 7 21 23 12 14 (19 ) 30 1.876% 60 8 24 19 78 27 1 (10) 37 (3) 2 22 9 21 23 5 9 21 12 1 22 2 27 89 10 11 6 A B 3 21 12 1 12 10 10 12 5 1 9 1 2 61 ( 21 10 1 11 30 )
<91E6825289F1938C966B95FA8ECB90FC88E397C38B5A8F708A778F7091E589EF8EC08D7388CF88F5837D836A83858341838B566572312E696E6464>
和県監査H15港湾.PDF
...1...1...1...1...1...1...1...1...2...2...2...3...3...3...5...5...10...11...12...13...13...13...14...14...14...14...14...14...15...15...15...15...15 ...16...17 14...17...18...18...19...21...23 2...25...27...27...28...28...28
( )
( ) () () 3 cm cm cm cm cm cm 1000 1500 50 500 1000 1000 1500 1000 10 50 300 1000 2000 1000 1500 50 10 1000 2000 300 50 1000 2000 1000 1500 50 10 1000 2000 300 30 10 300 1000 2000 1000 1500 1000
2002 (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (6) (7) (8) (1) (2) (3) (4) (1) (2) (3) (4) (5) (6) (7) (8) No 2,500 3 200 200 200 200 200 50 200 No, 3 1 2 00 No 2,500 200 7 2,000 7
-26-
-25- -26- -27- -28- -29- -30- -31- -32- -33- -34- -35- -36- -37- -38- cm -39- -40- 1 2 3 4 4 3 2 1 5 5-41- -42- -43- -44- -45- -46- -47- -48- -49- -50- cm -51- -52- -53- -54- -55- -56- -57- -58- -59- -60-
-1- 4 1 2 4-2- -- 2 2 cm 0 80cm 2 80cm 80cm 80cm 50cm 80cm 50cm 6 80cm 100 50 50 cm 10 6 4 50cm 4 4 50cm -4- -5- cm 50cm 4 4 4 50cm 50cm 4 80cm 50cm 80cm 50cm 6 cm -6- 20 250cm 1 2 1 4 0cm 60cm cm cm 1
untitled
() () () () () ( ) () ( ) () ( ) () 2 () () 2 () () ( ) () () () 2 () () 2 3 ( ) () ( ) 2 3 4 () () 2 3 4 () () ( )( ) ( ) 2 ( ) 3 () () 2 3 () () 2 3 () () () () () () () () (( ) ( ) (( ))( )( ) ) 2 3
4 100g
100g 10 20 30 40 50 60 70 80 4 5 7 9 12 15 19 24 60 100 10 80 100 20 10 5 20 195 20-1- 60 60 15 100 60 100 15 15 15 100 15 15 60 100 10 60 100 100 15 10 10 60 100 15 10 15 10 5-2- 80 80 24 100 80 100 24
180 30 30 180 180 181 (3)(4) (3)(4)(2) 60 180 (1) (2) 20 (3)
12 12 72 (1) (2) (3) 12 (1) (2) (3) (1) (2) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (1) (2) 180 30 30 180 180 181 (3)(4) (3)(4)(2) 60 180 (1) (2) 20 (3) 30 16 (1) 31 (2) 31 (3) (1) (2) (3) (4) 30
... 6 1) 2) No. 01 02 03 04 05 06 07 08 09 10 11 12 No. 1 2 2 3 3cm 4 untitled
1....1 2....2 2.1...2 2.2...2 3....14 3.1...14 3.2...14 4....15 4.1...15 4.2...18 4.3...21 4.4...23 4.5...26 5....27 5.1...27 5.2...35 5.3...54 5.4...64 5.5...75 6....79 6.1...79 6.2...85 6.3...94 6.4...
113 120cm 1120cm 3 10cm 900 500+240 10 1 2 3 5 4 5 3 8 6 3 8 6 7 6 8 4 4 4 4 23 23 5 5 7
untitled
21 14 487 2,322 2 7 48 4 15 ( 27) 14 3(1867) 3 () 1 2 3 ( 901923 ) 5 (1536) 3 4 5 6 7 8 ( ) () () 9 10 21 11 12 13 14 16 17 18 20 1 19 20 21 22 23 21 22 24 25 26 27 28 22 5 29 30cm 7.5m 1865 3 1820 5
1948 1907 4024 1925 14 19281929 30 111931 4 3 15 4 16 3 15 4 161933 813 1935 12 17 11 17 1938 1945 2010 14 221 1945 10 1946 11 1947 1048 1947 1949 24
15 4 16 1988 63 28 19314 29 3 15 4 16 19283 15294 16 1930 113132 3 15 4 16 33 13 35 12 3 15 4 16 1945 10 10 10 10 40 1948 1907 4024 1925 14 19281929 30 111931 4 3 15 4 16 3 15 4 161933 813 1935 12 17 11
Microsoft Word - 入居のしおり.doc
1 1 2 2 2 3 2 4 3 5 3 6 3 7 3 8 4 1 7 2 7 3 7 4 8 5 9 6 9 7 10 8 10 9 11 10 11 11 11 12 12 13 13 1 14 2 17 3 18 4 19 5 20 6 22 (1) 24 (2) 24 (3) 24 (4) 24 (5) 24 (6) 25 (7) 25 (8) 25 (9) 25 1 29 (1) 29
河川砂防技術基準・基本計画編.PDF
4 1 1 1 1 1 2 1 2.1 1 2.2 2 2.3 2 2.4 2 3 2 4 3 2 4 1 4 1.1 4 1.2 4 2 4 2.1 4 2.2 4 2.3 5 2.4 5 2.5 5 2.5.1 5 2.5.2 5 2.6 5 2.6.1 5 2.6.2 5 2.6.3 5 2.6.4 5 2.6.5 6 2.7 6 2.7.1 6 2.7.2 6 2.7.3 6 2.7.4
JR 140 140 NTT NTT NTT 10 10km km 5km 17 1015 110 (21.0975km) 10km 5km 1.5km 2.5km 45 1045 20 1045 55 1125 1010 1145 1005 1140 GS 1.5km 2.5km 5km 10km
6 JR 140 140 NTT NTT NTT 10 10km km 5km 17 1015 110 (21.0975km) 10km 5km 1.5km 2.5km 45 1045 20 1045 55 1125 1010 1145 1005 1140 GS 1.5km 2.5km 5km 10km 255 040 545 401000 451005 1051200 501225 551040
阪神５年PDF.PDF
1995.1.17 N 0km 10 20 31 4,569 14,679 67,421 55,145 6,965 80 1,471 3,383 13,687 5,538 327 22 933 1,112 12,757 5,675 465 2 243 3,782 6,344 6,641 65 17 555 1,755 9,533 8,109 940 15 12 817 271 3,140 1 918
! 1 m 43 7 1 150 ( ) 100 ( ) 11.3m 30 800 ( ) 1680 20 15 1,253 ( ) 1,500 51 52 300 1 4 134 1000 3 600 ( ) 30 , 402 km (1702) ( 1 402 67 12 23 10 ( ) ( 25,000 ) (1701 ) 485 ( 20 ) 400 (1860 ) (1) (2)
untitled
60 547 547 4km [ ] 14 20 18 2,400 5,500 24 15 10,000 [ ] [ ] 1779 1779 1471-76 1914 1471-76 1779 1914 1779 1779 1914 1471-7676 1779 1471-76 1946 1914 59 8 25 30 1986 3km 2m 5 2km 18 6 [ ]
Microsoft Word - 01_表紙
1 2 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 7.0 190 km 30 62 63 64
渋谷区耐震改修促進計画
1 2 3 2 1,000 ( ) 1,500 ( ) 3 1,000 1 1,000 2,000 3 1,000 2,000 3 1,000 2,000 3 1,000 2,000 3 1,000 2,000 3 1,000 2,000 3 1,000 3 1,000 2,000 3 1,000 2,000 3 1,000 3 1,000 2 1,000 2,000 2 1,000 2,000 2
1,000m 875m1 6km
1,000m 875m1 6km 1,000m 875m 30 13 14 11 2 14 23 27 50 30 3 () 23 24 25 16,534 16,792 18,017 13,946 17,884 18,712 30,480 34,676 36,729 1 (25 ) () 395 1,420 1,343 1,756 1,364 1,599 1,184 1,278 1,619 1,324
一太郎 13/12/11/10/9/8 文書
(1) 17 3 (2) (3) (1) 1 (2) 2 (1) (2) (3) (4) (5) (6) (7) (8) 3 (1) 50 12.5km 1km (2) 16 1900 (3) 65 65 19 14 17.5 (4) 34 31 22 335 133 (5) 104 321 3 4 4 43 4 4 4 () 5 6 (1) (2) 7 8 (1) (2)24 24 (3) 9 (4)
私にとっての沖縄と独自性.PDF
6902117 2 1200km 48 11 46 36 40 (1) ( ) 3 1 1-1 1-2 2 (= ) 3 1. 14 14 ( ) ( 2001) ( ) ( ) 1390 1474 ( 2001) ( 4 ) ( ) 46 3000 ( ) = 5 1609 1602 ( 2001) 1-1 1-2 1-1 1-2 15 (2) 6 1314 ( ) (3) ( ) 1 ( 1993:48)
-1 - -2 - -3 - -4 - -5 - -6- -7 - 260-8 - -9 - - 10-104km2 194km 340 104km2 194km 340 -11 - - 12-10km 20km 30km 260 260 1km 2km 2000 10km 20km 30km 260 260 1km 2km 2000 260 260 1km 2km 2000 - 13 - ( 3
, , km 9.8km 10.5km 11.9km 14.4km 14.4km 34.1km 3.4km 31.7km 6.2km 7.3k
410 470 500 540 620 620 620 1,250 300 1,170 360 390 450 490 570 670 770 850 880 7.7km 9.8km 10.5km 11.9km 14.4km 14.4km 34.1km 3.4km 31.7km 6.2km 7.3km 8.9km 10.4km 12.9km 15.8km 19.0km 21.7km 22.4km 530
03-b-„FŒ{›xŒ¾-4.02
518( 30 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 6 Dec. 25 2003 1. * * Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS 58 6 519( 31 ) 9 5 2003 8 2004 7 14 565 701 258 (36.8%) 443 (63.2%) Staphylococcus aureus
Microsoft Word - 高橋＿国試講習会2006m.doc
2006 19 150 20 200 19 80 2 70 1 45 1 1 30 20 105 2 40 1 1 31 95 2 25 1 1 32 1. 2. 3. 4. 5. 1 [] 25 12.5% 2006/3 6 2 1 2 3 7 A a b c d 11 e B a b c d C a b c D a b E a b c d 2 15 16 17 18 19 20 2001 2002
研究紀要 第５号
3 4 5 6 7 8 a s d f a 9 10 s d a 11 12 s d f g 13 h j a d s 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 a 35 s 36 a 37 s 38 a 39 s 40 a 41 s d 42 f 43 44 46 47 48 49 50 a s d as d 51
THE JAPANESE JOURNAL OF ANTIBIOTICS 57 1 33( 33 ) 2002 JA * 1 * 2 2003 12 15 * 1) * 2) 34( 34 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 57 1 Feb. 1982 7 2002 (2002.4 2003.3) 1 174 131 (75.3%) 334 171 163 Staphylococcus
172( 38 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 57 2 Apr. 2002 1 19 6 2002 5 8 4 254 254 (PBP) 90 83 65 142 PBP pbp1a, pbp2x, pbp2b 121 (49%), pbp1a, pbp2x 30 (12%), pbp2x, pbp2b 16 (6%), pbp2x 61 (24%),